Login / Signup

Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.

Masanori AtsukawaAkihito TsubotaHidenori ToyodaKoichi TakaguchiChisa KondoTomomi OkuboAtsushi HiraokaKojiro MichitakaShinichi FujiokaHaruki UojimaTsunamasa WatanabeHiroki IkedaToru AsanoToru IshikawaYoshihiro MatsumotoHiroshi AbeKeizo KatoKunihiko TsujiChikara OgawaNoritomo ShimadaEtsuko IioShigeru MikamiYasuhito TanakaTakashi KumadaKatsuhiko Iwakiri
Published in: Journal of gastroenterology and hepatology (2018)
The present study demonstrated that elbasvir and grazoprevir are highly effective and safe for genotype 1b chronic hepatitis C Japanese patients with CKD, including those undergoing hemodialysis.
Keyphrases
  • hepatitis c virus
  • chronic kidney disease
  • end stage renal disease
  • hepatitis c virus infection
  • peritoneal dialysis
  • liver fibrosis